FDA approves new treatment for adults with relapsed or refractory large-b-cell lymphoma
February 10, 2021
Today, the U.S. Food and Drug Administration approved Breyanzi (lisocabtagene maraleucel), a cell-based gene therapy to treat adult patients with certain types of large B-cell lymphoma who have not responded to, or who have relapsed ...
chat_bubble0 Comment
visibility172 Views
Honeywell expands life sciences and software capabilities through acquisition of Sparta Systems
January 6, 2021
Honeywell today announced it has agreed to acquire privately held Sparta Systems for $1.3 billion in an all-cash transaction from New Mountain Capital. Sparta Systems is a leading provider of enterprise quality management software (QMS), including ...
chat_bubble0 Comment
visibility220 Views
FDA statement on following the authorized dosing schedules for COVID-19 vaccines
January 6, 2021
Two different mRNA vaccines have now shown remarkable effectiveness of about 95% in preventing COVID-19 disease in adults. As the first round of vaccine recipients become eligible to receive their second dose, we want to ...
chat_bubble0 Comment
visibility96 Views
